Nanalysis Announces Fourth Quarter and Full Year 2021 Conference Call
Nanalysis Scientific Corp. will release its fourth quarter and full year results for the year ending December 31, 2021 on Thursday, April 28, 2022, followed by a conference call at 5 PM ET. CEO Sean Krakiwsky and CFO Luke Caplette will lead the call. Investors can participate via phone or through a webcast. The release will provide insights into the company's financial performance and future strategies as a leader in portable MRI and NMR technology.
- Company will provide detailed financial results for 2021, allowing investors to assess performance.
- Continued innovation in portable NMR technology with plans for new product offerings.
- None.
Hosting Call at 5pm ET on Thursday, April 28th
CALGARY, AB, April 20, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications, announces that on Thursday, April 28, 2022 the Company will put out their fourth quarter and full year results release for year ending December 31, 2021. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Luke Caplette will host a conference call at 5:00 P.M. Eastern Time that same day.
Investors interested in participating on the live call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/YQa2M3LDolK, or on the investor relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #629645.
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.
Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.
With the recent acquisition of K'(Prime) Technologies Inc. (KPrime), the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-fourth-quarter-and-full-year-2021-conference-call-301528976.html
SOURCE Nanalysis Scientific Corp.
FAQ
When will Nanalysis Scientific Corp. announce its fourth quarter results?
What time is the Nanalysis Scientific Corp. conference call on April 28, 2022?
Who will host the Nanalysis Scientific Corp. conference call?
How can investors participate in the Nanalysis conference call?
What is the significance of Nanalysis's fourth quarter and full year results?
